Caitong International Asset Management’s Akero Therapeutics AKRO Stock Holding History

Caitong International Asset Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7	Closed	-$332	–	1854
2025 Q3	$332	Sell	7 -82	-92%	-$3.97K	﹤0.01%	1603
2025 Q2	$4.75K	Sell	89 -34	-28%	-$1.54K	﹤0.01%	1042
2025 Q1	$4.98K	Buy	+123	New	+$5.21K	﹤0.01%	1020

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caitong International Asset Management's AKRO Position: Q4 2025 in Review

Caitong International Asset Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 7 shares — an estimated $332 sold.

Caitong International Asset Management first reported a position in AKRO in Q1 2025 and held it in 3 quarters. The position peaked at $4.98K in Q1 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Caitong International Asset Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Caitong International Asset Management sold 7 Akero Therapeutics shares in Q4 2025, an estimated $332.
Caitong International Asset Management first reported a position in Akero Therapeutics in Q1 2025 and held it in 3 quarters.
Caitong International Asset Management's Akero Therapeutics position peaked at $4.98K in Q1 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Caitong International Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.